RE: RNS extract22 Aug 2021 16:51
Hi Lee,
As I mentioned, I am not working on the detailed numbers any longer as we now have audited and independently produced information both in the PFS and the TEO.
The PFS had a Breakeven at $6 which included the capex and we knew there was upside.
The TEO has been submitted using a revenue value of 6 and the rns advised of the below.
"Upon completion of the translation, a comparative analysis of the results generated by Oreall for the TEO and the independently compiled February 2019 Pre-Feasibility Study ("PFS") will be provided. There are substantial upgrades and modifications to the February 2019 PFS. Many of which are related to metallurgical improvements by the development of a flowsheet allowing for the capture of two concentrate products."
So we have a statement which is very specific as to upgrades, modifications and improvements yet you believe the actual result is an $800m reduction in NPV from the PFS.
As to an example of an acquirer and where Synergies may occur, Russian Copper is a good example, next door, the discoverer is on our board, we have a copper copper concentrate, they'll have their own smelter, there is an old MOU for investigating Synergies.
As for the road, we've seen no cash commitment from AMC towards this which we know is required for the BFS. I think it will outside of our scope and be a toll road built by the Russians.
Last time I checked, the value of the platinum, paladium, rhodium and copper was about $3.5bn, even after recoverability, that's a little bit more than a rounding benefit.
As you say, the follow on comparison will hopefully be informative